Form 8-K Chemours Co For: Nov 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- S&P 500, Dow futures inch up before inflation data; bank results in focus
- Oil prices surge as Iran deploys new tactics to target tankers
- Bank of America stock falls on earnings miss
- BlackRock earnings beat sends shares higher premarket
- ASML shares climb on raised 2026 outlook, capacity expansion plans
Chemours (CC) Tops Q3 EPS by 28c; adj.-EBITDA Rose ~59%
November 7, 2016 7:51 AM ESTChemours (NYSE: CC) reported Q3 EPS of $0.61, $0.28 better than the analyst estimate of $0.33. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.4 billion.
Highlights:
Continued progress on all transformation plan objectives, including cost reductions, growth initiatives and portfolio rationalizationImproved cash from operating activities by ~$440 million year-to-dateRetired $315 million of long term debt through October 31, 2016Generated ~$685 million in gross proceeds from Chemical Solutions divestituresIncreased full-year Adjusted EBITDA... More


